ACRS..BRUTAL Hot Rebound Play which is massive underpriced here trading wayyy below cash balance
ACRS = Market Cap $43 M / Cash $115 M or untill end 2021 / 1 Marketed Product / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Prodcuts which means HUGE upfront payments forthe company (more infos below)= CHEAPEST Biotech you can get at this time
Aclaris Therapeutics (ACRS)
Market Cap: $43 M Cash: $115 M or enough untill end 2021
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.